SIRT1 overexpression is an independent prognosticator for patients with esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SIRT1 overexpression is an independent prognosticator for patients with esophageal squamous cell carcinoma

Published:2018-04-10 Issue:1 Volume:13 Page:
ISSN:1749-8090
Container-title:Journal of Cardiothoracic Surgery
language:en
Short-container-title:J Cardiothorac Surg

Author:

Ma Ming-Chun,Chiu Tai-Jan,Lu Hung-I,Huang Wan-Ting,Lo Chien-Ming,Tien Wan-Yu,Lan Ya-Chun,Chen Yen-Yang,Chen Chang-Han,Li Shau-Hsuan

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Surgery,Pulmonary and Respiratory Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13019-018-0718-5.pdf

Reference38 articles.

1. Li SH, Chen CH, Lu HI, Huang WT, Tien WY, Lan YC, Lee CC, Chen YH, Huang HY, Chang AY, et al. Phosphorylated p70S6K expression is an independent prognosticator for patients with esophageal squamous cell carcinoma. Surgery. 2015;157(3):570–80.

2. Lu HI, Li SH, Huang WT, Rau KM, Fang FM, Wang YM, Lin WC, Tien WY. A comparative study of isolated and metachronous oesophageal squamous cell carcinoma with antecedent upper aerodigestive tract cancer. Eur J Cardiothorac Surg. 2013;44(5):860–5.

3. Li SH, Rau KM, Lu HI, Wang YM, Tien WY, Liang JL, Lin WC. Pre-treatment maximal oesophageal wall thickness is independently associated witeh response to chemoradiotherapy in patients with T3-4 oesophageal squamous cell carcinoma. Eur J Cardiothorac Surg. 2012;42(6):958–64.

4. Rutegard M, Charonis K, Lu Y, Lagergren P, Lagergren J, Rouvelas I. Population-based esophageal cancer survival after resection without neoadjuvant therapy: an update. Surgery. 2012;152(5):903–10.

5. Baba Y, Watanabe M, Shigaki H, Iwagami S, Ishimoto T, Iwatsuki M, Baba H. Negative lymph-node count is associated with survival in patients with resected esophageal squamous cell carcinoma. Surgery. 2013;153(2):234–41.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SIRT1 Promotes Chemoradiotherapy Resistance in Esophageal Squamous Cell Carcinoma;Oncology;2024-07-22

2. Sirtuin1 (sirt1) regulates the glycolysis pathway and decreases cisplatin chemotherapeutic sensitivity to esophageal squamous cell carcinoma;Cancer Biology & Therapy;2024-06-12

3. Benserazide, a cystathionine beta-synthase (CBS) inhibitor, potentially enhances the anticancer effects of paclitaxel via inhibiting the S-sulfhydration of SIRT1 and the HIF1-α/VEGF pathway;Frontiers in Pharmacology;2024-05-17

4. Modulation of sirtuins during monolayer chondrocyte culture influences cartilage regeneration upon transfer to a 3D culture environment;Frontiers in Bioengineering and Biotechnology;2022-12-06

5. miRNA Expression May Have Implications for Immunotherapy in PDGFRA Mutant GISTs;International Journal of Molecular Sciences;2022-10-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3